Susquehanna International Group
KYNB

Susquehanna International Group’s Kyntra Bio KYNB Stock Holding History

Susquehanna International Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-47,100
Closed -$414K – 13437
2025
Q4 		$414K Hold
47,100
– – ﹤0.01% 9227
2025
Q3 		$577K Sell
47,100
-8,400
-15% -$78.9K ﹤0.01% 8644
2025
Q2 		$294K Buy
55,500
+52,600
+1,814% +$384K ﹤0.01% 10379
2025
Q1 		$22.5K Buy
2,900
+268
+10% +$3.21K ﹤0.01% 12081
2024
Q4 		$34.9K Sell
2,632
-1,828
-41% -$17K ﹤0.01% 11805
2024
Q3 		$44.6K Sell
4,460
-21,268
-83% -$321K ﹤0.01% 11422
2024
Q2 		$572K Buy
25,728
+19,956
+346% +$617K ﹤0.01% 7932
2024
Q1 		$339K Buy
+5,772
New +$249K ﹤0.01% 9430
2023
Q3 		– Sell
-26,156
Closed -$1.77M – 12282
2023
Q2 		$1.77M Buy
26,156
+16,176
+162% +$6.69M ﹤0.01% 5407
2023
Q1 		$4.66M Buy
9,980
+7,308
+274% +$3.87M ﹤0.01% 3559
2022
Q4 		$1.07M Sell
2,672
-628
-19% -$241K ﹤0.01% 6036
2022
Q3 		$1.07M Sell
3,300
-852
-21% -$274K ﹤0.01% 6461
2022
Q2 		$1.1M Buy
4,152
+740
+22% +$189K ﹤0.01% 6296
2022
Q1 		$1.02M Sell
3,412
-2,868
-46% -$1,000K ﹤0.01% 7049
2021
Q4 		$2.21M Sell
6,280
-1,684
-21% -$524K ﹤0.01% 5278
2021
Q3 		$2.04M Sell
7,964
-8,308
-51% -$2.94M ﹤0.01% 5801
2021
Q2 		$10.8M Buy
16,272
+8,232
+102% +$4.74M ﹤0.01% 2796
2021
Q1 		$6.98M Sell
8,040
-1,908
-19% -$2.03M ﹤0.01% 3356
2020
Q4 		$9.22M Buy
9,948
+3,248
+48% +$3.41M ﹤0.01% 2593
2020
Q3 		$6.89M Sell
6,700
-1,308
-16% -$1.41M ﹤0.01% 2668
2020
Q2 		$8.11M Sell
8,008
-696
-8% -$646K ﹤0.01% 2385
2020
Q1 		$7.56M Sell
8,704
-3,672
-30% -$3.65M ﹤0.01% 2072
2019
Q4 		$13.3M Buy
12,376
+4
+0% +$4.08K ﹤0.01% 1799
2019
Q3 		$11.4M Buy
12,372
+3,140
+34% +$3.45M ﹤0.01% 1836
2019
Q2 		$10.4M Sell
9,232
-11,848
-56% -$13M ﹤0.01% 1839
2019
Q1 		$28.6M Buy
21,080
+7,664
+57% +$10.4M 0.01% 950
2018
Q4 		$15.5M Sell
13,416
-916
-6% -$1.03M 0.01% 1239
2018
Q3 		$21.8M Sell
14,332
-1,864
-12% -$2.87M 0.01% 1256
2018
Q2 		$25.3M Sell
16,196
-3,320
-17% -$4.33M 0.01% 1110
2018
Q1 		$22.5M Buy
19,516
+2,212
+13% +$2.91M 0.01% 1132
2017
Q4 		$20.5M Sell
17,304
-3,508
-17% -$4.4M 0.01% 1231
2017
Q3 		$28M Buy
20,812
+10,756
+107% +$11.3M 0.01% 995
2017
Q2 		$8.12M Buy
10,056
+780
+8% +$543K ﹤0.01% 1878
2017
Q1 		$5.72M Sell
9,276
-184
-2% -$112K ﹤0.01% 2216
2016
Q4 		$5.06M Buy
9,460
+5,584
+144% +$2.79M ﹤0.01% 2420
2016
Q3 		$2.01M Buy
3,876
+2,576
+198% +$1.21M ﹤0.01% 3569
2016
Q2 		$533K Sell
1,300
-1,664
-56% -$762K ﹤0.01% 6003
2016
Q1 		$1.58M Buy
2,964
+548
+23% +$273K ﹤0.01% 4213
2015
Q4 		$1.84M Sell
2,416
-920
-28% -$611K ﹤0.01% 4209
2015
Q3 		$1.83M Buy
3,336
+1,488
+81% +$901K ﹤0.01% 4464
2015
Q2 		$1.09M Buy
+1,848
New +$1.07M ﹤0.01% 6047

Other funds holding KYNB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's KYNB Position: Q2 2025 in Review

Susquehanna International Group sold out of Kyntra Bio (KYNB) in Q2 2025, closing a stake of 2,327 shares — an estimated $17K sold.

Susquehanna International Group first reported a position in KYNB in Q4 2014 and held it in 36 quarters. The position peaked at $22.4M in Q4 2018. 30 funds tracked by Wall St. Rank hold KYNB as of Q2 2025.

  • Susquehanna International Group reported no remaining Kyntra Bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 2,327 Kyntra Bio shares in Q2 2025, an estimated $17K.
  • Susquehanna International Group first reported a position in Kyntra Bio in Q4 2014 and held it in 36 quarters.
  • Susquehanna International Group's Kyntra Bio position peaked at $22.4M in Q4 2018.
  • 30 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.